Studies showing that human tumor cells themselves are able to activate MAPK-mediated IL8 and VEGF expression by binding of MIF to its main receptor CD747,12,27,28,35,53 were confirmed within this study in human CRC cells (Fig. 5). This evidence concerns the gene MIF and colorectal carcinoma.